First in Human Study of SIM0610 in Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
China
Chongqing Cancer Hospital, Chongqing, Chongqing Municipality Harbin Medical University Cancer Hospital, Harbin, Heilongjiang the First Hospital of China Medical University, Shenyang, Liaoning The Affiliated Cancer Hospital of Shandong First Medical University& Shan Dong Cancer Hospital, Jinan, Shandong Shanghai East Hospital, Shanghai, Shanghai Municipality Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality Age range
18 Years and older
Last updated January 2026